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We investigated dengue virus (DENV) and asymptomatic 
DENV infections in rural villages of Kampong Cham Prov-
ince, Cambodia, during 2012 and 2013. We conducted 
perifocal investigations in and around households for 149 
DENV index cases identified through hospital and village 
surveillance. We tested participants 0.5–30 years of age by 
using nonstructural 1 rapid tests and confirmed DENV infec-
tions using quantitative reverse transcription PCR or non-
structural 1–capture ELISA. We used multivariable Poisson 
regressions to explore links between participants’ DENV in-
fection status and household characteristics. Of 7,960 study 
participants, 346 (4.4%) were infected with DENV, among 
whom 302 (87.3%) were <15 years of age and 225 (65.0%) 
were <9 years of age. We identified 26 (7.5%) participants 
with strictly asymptomatic DENV infection at diagnosis and 
during follow-up. We linked symptomatic DENV infection 
status to familial relationships with index cases. During the 
2-year study, we saw fewer asymptomatic DENV infections 
than expected based on the literature.
Annually, ≈390 million people in >100 countries are infected with dengue virus (DENV); 70% of cases 
occur in countries in Asia (1). DENV is a flavivirus trans-
mitted by Aedes aegypti and Ae. albopictus anthropo-
philic female mosquitoes. DENV has 4 distinct serotypes, 
DENV-1–4 (2); DENV infections can range from asymp-
tomatic to life-threatening.
In Cambodia, the national dengue surveillance system 
reported 60,000 cases and 135 deaths attributed to DENV 
in 2012 and 2013 (3). Syndromic surveillance and random 
testing of dengue-like cases in referral pediatric hospitals 
in Cambodia likely underestimate the true disease burden 
(4). By definition, syndromic surveillance does not detect 
asymptomatic DENV infections, which increase vector 
transmission potential (5). Mammen et al. used both den-
gue-positive and dengue-negative index cases of febrile 
children to initiate perifocal investigations and found no 
cases in proximity to dengue-negative index cases (6). To 
maximize the number of recruited cases, we investigated 
homes around preidentified, dengue-positive index cases, 
as per a previous study (7). Our objectives were to docu-
ment the proportion of strictly asymptomatic infections 
in this region of Cambodia; characterize human, sociode-
mographic, household-level, and mosquito control–related 
factors associated with DENV infection; and identify fac-
tors associated with asymptomatic DENV infection.
Methods
Ethics Considerations
The study protocol was approved by the Cambodian 
National Ethics Committee on Health Research. We ob-
tained informed consent from participants or their guard-
ians documented during hospital or village surveillance or 
perifocal investigations.
Study Site
We conducted a study in rural villages of Kampong Cham 
Province, 120 km northeast of Cambodia’s capital, Phnom 
Penh. The study area included 368 villages with ≈60,000 
households and 3 hospitals within a 30-km radius. Dengue 
is endemic in the region and mainly affects children <15 
years of age during the annual rainy season (June–October). 
Identification of Dengue Index Cases in  
Hospitals and Villages 
During June 1–October 31, 2012 and 2013, we identified 
DENV index cases in 3 referral hospitals and 26 villages 
Asymptomatic Dengue Virus  
Infections, Cambodia, 2012–2013
Sowath Ly,1 Camille Fortas,1 Veasna Duong, Tarik Benmarhnia, Anavaj Sakuntabhai, Richard Paul, 
Rekol Huy, Sopheak Sorn, Kunthy Nguon, Siam Chan, Souv Kimsan, Sivuth Ong, Kim Srorn Kim, 
Sowathy Buoy, Lim Voeung, Philippe Dussart, Philippe Buchy,1,2 Arnaud Tarantola1
1These authors contributed equally to this article.
2Current affiliation: GlaxoSmithKline Vaccines Research and 
Design, Singapore.
Author affiliations: Institut Pasteur du Cambodge, Phnom Penh, 
Cambodia (S. Ly, C. Fortas, V. Duong, S. Sorn, K. Nguon,  
S. Chan, S. Kimsan, S. Ong, P. Dussart, P. Buchy, A. Tarantola); 
University of California, San Diego, California, USA  
(T. Benmarhnia); Institut Pasteur, Paris, France (A. Sakuntabhai, 
R. Paul); Malaria National Center, Phnom Penh (R. Huy);  
Kampong Cham Provincial Hospital, Kampong Cham, Cambodia 
(K.S. Kim); Prey Chhor District Referral Hospital, Kampong Cham 
(S. Buoy); Tboung Khmum District Referral Hospital, Thoung 
Khmum, Cambodia (L. Voeung)
DOI: https://doi.org/10.3201/eid2507.181794
RESEARCH
 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 25, No. 7, July 2019 1355
under active surveillance for febrile illness (5). We targeted 
persons 0.5–30 years of age. In the 3 hospitals, blood sam-
ples were drawn at admission and discharge for all patients 
suspected of having DENV infection on the basis of clinical 
assessment and platelet count. In the 26 villages, volunteers 
monitored eligible residents weekly, measuring axillary body 
temperature using a digital thermometer to identify persons 
with temperatures >38°C. Blood samples were drawn 1–2 
days after fever onset, as described elsewhere (4,8,9). All sam-
ples were screened for DENV infection by using a nonstruc-
tural (NS) 1 IgM/IgG combination rapid test. We confirmed 
DENV by using quantitative reverse transcription PCR (qRT-
PCR) or NS1-capture ELISA and included case-patients with 
confirmed DENV infection as index cases in the study.
Perifocal Investigations
Within 1–2 days of identifying an index case, whether from 
village or hospital surveillance, we began a perifocal inves-
tigation of the index case-patient’s village of origin (7). For 
each perifocal investigation, we used a rapid dengue test 
kit to screen eligible residents in the index case-patient’s 
household for DENV and completed a baseline question-
naire on individual symptoms, socioeconomic status, and 
household characteristics. We did the same in 20 house-
holds in a 100-meter radius of the index case-patient’s 
household. We included persons 0.5–30 years of age who 
consented or whose guarantor consented. We tested adults 
>20 years of age during the first year of the study but found 
no DENV-positive cases and did not test this age group 
during the second year. All consecutive cases were eligible 
for inclusion. To avoid bias through overlapping investi-
gations of a potentially common source of infection, we 
did not conduct a perifocal investigation within 1 week of 
a previous investigation for >2 index cases consecutively 
detected from the same village.
DENV Testing and Case Definitions
To screen for DENV infection during surveillance and 
perifocal investigations, investigators tested all blood 
samples on-site using SD BIOLINE Dengue Duo kit (Stan-
dard Diagnostics, https://www.alere.com), according to 
the manufacturer's instructions. Investigators interpreted 
results within 15–20 minutes and ruled out possible cas-
es if the control band was negative. Blood samples from 
DENV-positive participants were sent to Institut Pasteur du 
Cambodge (Phnom Penh, Cambodia) for qRT-PCR testing, 
as described previously (10,11), or confirmation using an 
NS1-capture ELISA (11,12) with positive controls diluted 
to the limit of detection, negative, and nontemplate controls 
used during extraction and PCR steps to reduce inaccura-
cies (10). We considered cases confirmed when a blood 
sample tested positive by NS1 rapid test and was confirmed 
by NS1-capture ELISA or qRT-PCR. During the first year, 
we also tested participants for Japanese encephalitis virus 
(JEV) and chikungunya virus (CHIKV) IgM antibodies 
by ELISA and confirmed IgM-positive results using spe-
cific RT-PCR to ensure that symptoms were not related to 
CHIKV, JEV, or co-infections (11–13).
Symptomatic DENV-confirmed case-patients had fe-
ver, muscle or joint pain, rash, bleeding, prolonged head-
aches, or digestive signs. We asked participants whether 
they had taken antipyretics in the previous 24 hours. We 
termed afebrile all symptomatic DENV-positive partici-
pants without a fever and no antipyretic use. We consid-
ered participants asymptomatic when they had confirmed 
DENV infection, no antipyretic use, and no signs or symp-
toms, including fever. Participants who were symptomatic 
at initial diagnosis on day 0 received follow-up monitoring 
on days 2 and 7. We monitored asymptomatic participants 
daily on days 0–7 and again on day 10 using a question-
naire to document signs and symptoms of DENV. In our 
analyses, we recategorized participants who were asymp-
tomatic at baseline to symptomatic if they reported any 
symptoms during the follow-up period.
Statistical Analysis
We described DENV infection attack rates for perifocal 
investigations and the proportion of asymptomatic cases 
among all DENV infections and circulating serotypes. To 
explore participant- and household-level factors associated 
with DENV infection, we conducted a multivariable Pois-
son regression estimating attack rate ratios (ARRs) (14), 
excluding index cases. We built explanatory models around 
each participant-level and household-level factor, with and 
without adjusting for covariates. Participant-level factors 
included age, sex, occupation or schooling, and relation-
ship to an index case-patient. Because we found collinear-
ity between age and occupation, we adjusted only for age. 
We placed participants 0.5–1 year of age into a specific cat-
egory to account for differences in immunity and exposure 
to vectors due to reduced mobility. Household-level fac-
tors included the main source of income, source of water, 
measures against mosquitoes, and environmental factors 
favorable to mosquito development. We further divided the 
source of water into 2 categories: piped water (from indoor 
or outdoor taps with a tube well and pump) or nonpiped 
water (from a pond, river, lake, or a well without pump).
Considering the limited flight range of a female Aedes 
mosquito, we assumed that the probability of DENV trans-
mission would be higher within a household than across 
households. To account for this factor and measure poten-
tial clustering, we developed a random-effects multilevel 
model. We computed the intraclass correlation coefficient 
as the proportion of the variability in the probability of 
infection attributable to differences between households 
versus differences within households (15). We excluded 
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19 participants with missing covariates or predictors from 
the regression analyses. We explored associations between 
asymptomatic DENV infection and DENV serotype, par-
ticipant-level factors, and the main source of income as so-
cioeconomic indicators. We used the Fisher exact test for 
comparing proportions, the Student t test for means, and 
an empty multilevel model to search for a cluster effect. 
We conducted analyses using Stata version 13 (StataCorp, 
https://www.stata.com).
Results
Dengue Surveillance for Index Case Identification
We identified 1,294 suspected DENV-infected persons, 
834 (64.5%) among hospital inpatients and 460 (35.5%) 
through febrile illness surveillance in villages. Our testing 
confirmed 555 (66.5%) DENV-positive cases among hos-
pital patients and 36 (7.8%) DENV-positive cases through 
febrile illness surveillance in villages.
Perifocal Investigations
From the 591 DENV-positive patients, we selected 149 
(25.2%) consecutive cases for which we conducted perifocal 
investigations: 131 from hospital patients, termed PI-H, and 
18 from village febrile surveillance, termed PI-V. Perifocal 
investigations took place in 104 villages over the 2 rainy sea-
sons and documented 7,960 participants, 6,811 (86%) male 
and 1,149 (14%) female, in 2,988 households (Figure). 
We found 346 (4.3%) persons who were positive for 
DENV infection, 225 (65.0%) of whom were <9 years 
of age. We determined attack rates of 14.7/1,000 partici-
pants (14/952) in PI-V and 47.4/1,000 (332/7,008) in PI-H 
(p<0.05). The attack rate over the 2 outbreak seasons in-
creased marginally from 37/1,000 persons 0.5–30 years of 
age during the 2012 season to 46/1,000 among those 0.5–
20 years of age during 2013 (p = 0.056). Only 26 (7.5%) 
of 346 DENV-positive participants remained strictly 
asymptomatic during the 10-day follow-up, an asymptom-
atic DENV-infection attack rate of 3.3/1,000 over the 2 
years of our study. The proportion of asymptomatic infec-
tions was 21.4% (3/14) in PI-V and 6.9% (23/332) in PI-H. 
Besides headache and fever, symptomatic case- 
patients mainly experienced muscle, retro-orbital, and 
joint pain. Although fever is considered a typical symptom 
of DENV infection, careful interview, rigorous clinical 
assessment, and follow-up interviews showed that partici-
pants remained afebrile in 110 (31.8%) of the 320 symp-
tomatic DENV infections, even without antipyretics. Only 
6 (1.7%) of the DENV-positive case-patients required hos-
pitalization, 2 with bleeding. 
The 2 annual outbreaks were dominated by DENV-1. 
However, DENV-2 and DENV-4 emerged in 2013, and 
we detected DENV-3 sporadically (Table 1). During the 
first year of the study, samples from all symptomatic and 
asymptomatic DENV cases were negative for CHIKV by 
MAC-ELISA. Because we diagnosed no CHIKV in year 
1, and our national surveillance system also did not detect 
any CHIKV cases (data not shown), we did not perform 
CHIKV testing during year 2. Of 26 asymptomatic cases 
confirmed by qRT-PCR or NS1-capture ELISA, 6 had 
positive JEV serology and also were positive for DENV 
IgM. We could not conclude whether JEV-positive results 
were indicative of a recent or acute JEV co-infection or the 
result of cross-reaction among flaviviruses. Among hospi-
talized patients, 2 had positive JEV results without detect-
able DENV IgM, even though qRT-PCR or NS1-capture 
ELISA was positive. These results could suggest a recent 
or acute JEV co-infection. During perifocal investigations, 
42 participants tested positive for JEV by MAC-ELISA 
Figure. Participant screening and data flowchart for perifocal 
investigations for asymptomatic DENV infection, Cambodia, 
2012–2013. Initial DENV screening of febrile cases was 
conducted using nonstructural (NS) 1 IgM/IgG combo rapid test. 
Perifocal investigations took place in villages of index cases; we 
screened all persons in 20 households within a 100-m radius of an 
index case household. We excluded persons <0.5 and >30 years 
of age. Laboratory confirmation of DENV was conducted through 
quantitative reverse transcription PCR or NS1-capture ELISA. 
DENV, dengue virus; PI-H, perifocal investigations conducted for 
index cases identified through hospital surveillance; PI-V, perifocal 
investigations conducted for index cases identified through village 
febrile surveillance.
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with negative DENV results, NS1, and qRT-PCR, support-
ing evidence of JEV co-circulation in the country (16). 
Screened participants had a mean age (+ SD) of 11.7 
(+ 7.9; median 10; interquartile range 6–16); 6,207 (77.9%) 
were schoolchildren, university students, or nonschooled 
children. The main sources of household income were 
planting crops (61.0%), working in a factory (14.3%), and 
keeping a shop (13.4%). Participants reported low use of 
protective measures against mosquitoes, including mos-
quito coils in 787 (26.3%) households, insecticide sprays 
in 557 (18.6%) households, and larvicidal temephos in 
374 (12.5%) households. Our investigation found uncov-
ered water jars in 1,867 (62.7%) households and mosquito 
larvae in water containers of 1,663 (55.7%) households 
(Table 2).
Among DENV-positive cases, boys and girls were 
equally affected at a mean (+ SD) age of 8.5 (± 5.7) years. 
Compared with persons 15–30 years of age, we found that 
children 1–10 years of age had a higher ARR of DENV 
infection (ARR 4.04 [95% CI 2.72–5.98] for those 1–5 
years of age and ARR 3.83 [95% CI 2.59–5.67] for those 
6–10 years of age). Siblings and cousins of index case-
patients were more prone to DENV infection than neigh-
bors were; siblings were 2.24 (95% CI 1.42–3.53) times 
and cousins 1.40 (95% CI 1.02–1.90) times more at risk for 
infection than neighbors. Participants who used piped wa-
ter had a higher risk for DENV infection (ARR 1.35 [95% 
CI 1.06–1.71]) than did those who used nonpiped water. 
Households in which the main source of income was fish-
ing, farming, or animal husbandry also had higher risks for 
infection (ARR 2.02 [95% CI 1.18–3.45]). Households re-
porting mosquito control–related parameters did not have a 
lower risk for DENV infection (Table 2). 
The main source of income was similarly distributed 
between households with ≥1 case and households with no 
cases (p = 0.272). Our multilevel model showed a notable 
clustering effect at the household level after adjustment (in-
traclass correlation coefficient 40.8%).
We found 26 (7.5%) case-patients, 17 (65.4%) male 
and 9 (34.6%) female, who were positive for DENV in-
fection but remained asymptomatic. We found serotypes 
DENV-1, DENV-2, and DENV-4 in our study group (Ta-
ble 3). We used a multilevel approach to explore the role 
of specific serotypes and participant-level factors, such as 
age, gender, and relationship to the index case-patient, a 
proxy for common genetic background, with being DENV-
positive and asymptomatic. We found that only family 
relationship to the index case-patient was associated with 
asymptomatic infection. We did not identify a cluster effect 
or associated factors.
Discussion
We screened 7,960 participants in communities in Cambo-
dia during 2012 and 2013 and found 346 (4.3%) participants 
 
Table 1. Surveillance data from perifocal investigations for asymptomatic dengue virus, Cambodia, 2012–2013* 
Surveillance data 2012 2013 Total 
No. participants 2,391 5,569 7,960 
No. villages investigated 35 77 104 
No. perifocal investigations conducted 47 102 149 
Mean no. participants per perifocal investigation 51 55 53 
Confirmed infections, no. (%) 88 258 346 
 Strictly asymptomatic 5 (5.7) 21 (8.1) 26 (7.5) 
 Afebrile 33 (37.5) 77 (29.8) 110 (31.2) 
 Symptomatic 83 (94.3) 237 (91.9) 320 (92.5) 
Attack rate/1,000 participants, % 36.8 46.3 43.5 
 Asymptomatic infections 2.1 3.8 3.3 
 Symptomatic infections 34.7 42.6 40.2 
  Afebrile infections 13.8 13.8 13.8 
Symptoms at diagnosis or follow-up, no. (%)  83 237 320 
 Fever 55 (66.2) 180 (75.9) 236 (73.8) 
 Headache 52 (62.7) 169 (71.3) 221 (69.1) 
 Muscle pain 16 (19.3) 73 (30.8) 89 (27.8) 
 Retro-orbital pain 17 (20.5) 73 (30.8) 90 (28.1) 
 Joint pain 17 (20.5) 68 (28.7) 85 (26.5) 
 Rash 15 (18.1) 53 (22.4) 68 (21.3) 
 Any bleeding 13 (15.7) 50 (21.1) 63 (19.7) 
Hospitalizations, no. (%) 3 (3.5) 8 (3.3) 11 (3.3) 
DENV infections 88 258 346 
 Serotype, no. (%)    
  DENV-1 82 (98.8) 188 (72.9) 270 (78.0) 
  DENV-2 1 (1.2) 36 (13.9) 37 (10.7) 
  DENV-3 0 2 (0.8) 2 (0.6) 
  DENV-4 0 31 (12.0) 31 (9.0) 
  DENV-1 and DENV-2 0 1 (0.4) 1 (0.3) 
  Missing 5 0 5 
*Participants 0.5–30 years of age in 2012 and 0.5–20 years of age in 2013. DENV, dengue virus. 
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infected by DENV; 26 (7.5%) remained asymptomatic be-
fore, during, and after our study. We found comparable at-
tack rates, 37/1,000 persons in 2012 and 46/1,000 persons in 
2013, to other community investigations conducted in Cam-
bodia. For instance, another study reported DENV attack 
rates of 13.4–57.8 cases/1,000 persons during 2006–2008 
(4). Previous studies only included participants ≤20 years 
of age, but we included persons 0.5–30 years of age with 
confirmed DENV infection, even symptomatic but afebrile 
case-patients, who were 31.8% of the DENV infections in 
 
Table 2. Participant and household characteristics with unadjusted and adjusted attack rate ratios for factors potentially associated 
with dengue virus infection, Cambodia, 2012–2013* 
Characteristics Infected Uninfected Total 
Unadjusted ARR 
(95% CI) 
Adjusted ARR 
(95% CI) 
Participants 346 7,614 7,960   
 Sex      
  M 171 4,103 4,272 Referent Referent 
  F 175 3,511 3,686 1.14 (0.92–1.40) 1.01 (0.82–1.24) 
 Age, y†      
  0.5–<1  9 (2.6) 150 (2.0) 159 (2.0) 3.47 (1.65–7.32) 3.53 (1.67–7.46) 
  1–<5  108 (31.2) 1,701 (22.3) 1,809 (22.7) 3.98 (2.69–5.90) 4.04 (2.72–5.98) 
  5–<10  126 (36.4) 2,083 (27.4) 2,209 (27.8) 3.79 (2.56–5.60) 3.83 (2.59–5.67) 
  10–<15 71 (20.5) 1,675 (22.0) 1,746 (21.9) 2.59 (1.70–3.94) 2.55 (1.67–3.88) 
  15–30 32 (9.3) 2,005 (26.3) 2,037 (25.6) Referent Referent 
 Mean (+ SD, median) 8.5 (+ 5.7, 7) 11.9 (+ 8.0, 10) 11.7 (+ 7.9, 10) – – 
 Occupation‡      
  Student, school or university 171 (49.8) 3,588 (47.2) 3,759 (47.3) 2.14 (1.35–3.41) 2.14 (1.34–3.41) 
  Preschool or unschooled 149 (43.2) 2,299 (30.2) 2,448 (30.8) 2.84 (1.79–4.54) 2.84 (1.78–4.54) 
  Planting crops 20 (5.8) 910 (12.0) 930 (11.7) Referent Referent 
  Other 5 (1.5) 809 (10.6) 814 (10.2) 0.28 (0.10–7.76) 0.28 (0.10–7.76) 
  Missing 1 (0.2) 8 (0.1) 9 (1.1)   
 Relationship to index case-patient§      
  Neighbor 260 (75.4) 6,309 (83.0) 6,569 (82.6) Referent Referent 
  Cousin 58 (16.8) 991 (13.0) 1,049 (13.2) 1.38 (1.01–1.89) 1.40 (1.02–1.90) 
  Sibling 23 (6.7) 251 (3.3) 274 (3.5) 2.11 (1.33–3.34) 2.24 (1.42–3.53) 
  Other 5 (1.2) 55 (0.7) 59 (0.7) 1.66 (0.59–4.65) 1.76 (0.34–4.90) 
  Missing 1 (0.2) 8 (0.1) 9 (1.1)   
Households 292¶ 2,706 2,988   
 Water source#      
  Nonpiped 108 (36.3) 1,186 (43.7) 1,284 (43.0) Referent Referent 
  Piped 184 (63.7) 1,520 (56.3) 1,704 (57.0) 1.32 (1.03–1.69) 1.35 (1.06–1.71) 
 Primary source of income**      
  Planting crops 176 (60.9) 1,648 (61.0) 1,824 (61.0) Referent Referent 
  Working in a factory 42 (14.5) 384 (14.2) 426 (14.3) 1.16 (0.84–1.62) 1.20 (0.87–1.66) 
  Shopkeeping 37 (12.8) 362 (13.4) 399 (13.4) 0.97 (0.67–1.40) 1.03 (0.72–1.48) 
  Fishing, farming, animal husbandry 14 (4.8) 55 (2.0) 69 (2.3) 1.98 (1.15–3.43) 2.02 (1.18–3.45) 
  Working in government 5 (1.7) 57 (2.1) 62 (2.1) 0.94 (0.38–2.30) 0.99 (0.41–2.37) 
  Other 15 (5.2) 193 (7.2) 208 (7.0) 0.76 (0.43–1.32) 0.85 (0.50–1.46) 
 Mosquito control measures††      
  Temephos  26 (9.0) 348 (12.9) 374 (12.5) 0.70 (0.47–1.06) 0.73 (0.48–1.10) 
  Larvivorous fish 26 (9.0) 214 (7.9) 240 (8.3) 1.14 (0.75–1.74) 1.18 (0.78–1.79) 
  Treated mosquito netting 27 (9.3) 311 (11.5) 338 (11.3) 0.78 (0.52–1.17) 0.82 (0.55–1.21) 
  Treated jar cover 3 (1.0) 47 (1.7) 50 (1.7) 0.73 (0.24–2.24) 0.77 (0.26–2.27) 
  Coils 77 (26.6) 710 (26.3) 787 (26.3) 1.08 (0.82–1.41) 1.16 (0.89–1.51) 
  Insecticide spray 44 (15.2) 513 (19.0) 557 (18.6) 0.79 (0.57–1.10) 0.88 (0.63–1.22) 
 Environmental factors**      
  Vegetable garden 57 (9.7) 546 (20.2) 603 (20.2) 0.89 (0.66–1.21) 0.89 (0.66–1.20) 
  Water collection around house 126 (43.6) 1,180 (43.7) 1,306 (44.7) 0.91 (0.71–1.15) 0.88 (0.70–1.12) 
  Uncovered water jars 178 (61.6) 1,689 (62.6) 1,867 (62.5) 0.96 (0.75–1.22) 0.97 (0.76–1.23) 
  Larvae in water containers 168 (58.1) 1,495 (55.4) 1,663 (55.7) 1.09 (0.86–1.39) 1.07 (0.85–1.37) 
  Distance from house to nearest  
  water jar, m (+ SD) 
1.5 (+ 2.2) 1.3 (+ 2.0) 1.3 (+ 2.0) 1.00 (0.98–1.02) 1.00 (0.98–1.02) 
  Missing for all items 3 7 10   
*Values are no. or no. (%) except as indicated. ARR, attack rate ratio; DENV, dengue virus. 
†Participants 0.5–30 years of age in 2012 and 0.5–20 years of age in 2013.  
‡Adjusted for sex. 
§Adjusted for age. 
¶No. housesholds with >1 DENV case. 
#Nonpiped water comes from a river, pond, lake, or a well that does not have a pump; piped water comes from indoor or outdoor taps with a tube well and 
pump.  
**Adjusted for sex and occupation. 
††Adjusted for age, relationship to index case-patient, occupation, and primary source of income. 
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this study. We noted that attack rates were lower in PI-V, 
14.7/1,000 participants (14/952), than in PI-H, 47.4/1,000 
participants (332/7,008). Circulation of DENV around fe-
brile index case-patients identified through PI-V was less 
intense, but with more asymptomatic cases, than around in-
dex case-patients identified through PI-H. Aside from pos-
sible detection biases (17), multiple factors could explain 
this observation and deserve further research.
Our study documented cases of DENV infection in trans-
mission clusters located around index case-patients. We found 
that 26.6% of DENV-confirmed case-patients reported clini-
cal symptoms, including headache and muscle pain, but no 
fever even in the absence of antipyretics, comparable to data 
from Thailand, where 40.4% of the DENV cases remained 
afebrile (17). The appearance of afebrile DENV-infected pa-
tients raises potential concerns for case definitions for detec-
tion, especially of imported cases in at-risk countries.
An additional 7.5% of DENV-confirmed case-patients 
had no symptoms during the 10-day course of clinical 
monitoring, a considerably lower rate than estimates from 
other prospective studies (5,18–21). Published sources refer 
to inapparent infections, often defined as afebrile clinical 
complaints with biologic evidence of DENV infection, rang-
ing from 20% to 80% of cases (19,22,23). Previous studies 
used different definitions of asymptomatic infection than 
ours, but the major difference lies in follow-up monitoring. 
Other retrospective studies used school or work absentee-
ism as a basis for follow-up (19). Strictly asymptomatic 
patients, such as those we describe, escape detection by sur-
veillance or control measures, infect mosquitoes, and might 
disproportionately contribute to DENV transmission (5).
The DENV burden documented through hospital-
based surveillance of febrile case-patients in Thailand and 
Vietnam showed a shift to older age groups (24,25). Our 
active, systematic case-finding system to identify DENV in 
villages in Cambodia found the attack rate was highest in 
children <10 years of age, which is what we expected in a 
dengue-endemic country with frequent outbreaks demon-
strated in other careful studies (26). This finding raises con-
cerns because recommendations for the only licensed den-
gue vaccine are for use in persons 9–45 years of age with 
demonstrated evidence of past DENV infection (27). Our 
study demonstrates that children in rural Cambodia might 
have undergone >1 DENV infection before 9 years of age, 
reducing the potential cost-effectiveness of vaccination.
Few studies have explored the role of socioeconom-
ic status, which might be a proxy for peridomestic envi-
ronmental management, on DENV infection in Southeast 
Asia. Often, the direction of the association is unclear and 
socioeconomic status has entirely different associations de-
pending on the setting (28). Our study shows that the ad-
justed risk for DENV infection was highest in households 
in which the main source of income was from fishing, farm-
ing, or animal husbandry, activities associated with lower 
average household income in Cambodia.
We found temephos provided no additional protection 
against DENV infection after adjusting for other factors. 
Although temephos is effective in reducing Aedes spp. lar-
val populations in water storage jars, its use did not cor-
relate with lower DENV transmission in Cambodia or else-
where (8), due to incorrect distribution coverage, dosage, 
and placement (29) or multiple vector breeding sites. In ad-
dition, increases in temephos-resistant A. aegypti mosquito 
larvae have been documented in Cambodia (30).
Unexpectedly, we found a higher risk for DENV with 
piped water as a main water source after adjusting for other 
factors, contrary to a study in Thailand (6). However, piped 
water with suboptimal sanitation in Cambodia might contrib-
ute to collection of water in or around households that could 
become breeding sites for DENV-transmitting mosquitoes.
We found that 40.8% of the variability in probabil-
ity of being DENV infected was explained by differences 
between households. Those living in the same household 
as an index case-patient were 2.11 times more likely to be 
 
Table 3. Univariate tests for associations between 
sociodemographic factors and infecting serotypes with 
asymptomatic dengue virus infections, Cambodia, 2012–2013* 
Factor 
Asymptomatic, 
n = 26 
Symptomatic, 
n = 320 p value† 
Sex    
 M 17 154 0.09 
 F 9 166 
Age, y    
 0.5 to <1 0 9 (2.8) 0.976 
 1–5 9 (34.6) 99 (30.9) 
 6–10 9 (34.6) 117 (36.6) 
 11–14 5 (19.2) 66 (20.6) 
 15–30 3 (11.5) 29 (9.1) 
 Mean  
 (+ SD, median) 
9.2  
(+ 7.2, 8) 
11.0  
(+ 7.1, 10) 
Relationship to index case-patient   
 Neighbor 17 (65.4) 243 (76.0) 0.004 
 Cousin 5 (19.2) 53 (16.6) 
 Sibling 1 (3.9) 22 (6.9) 
 Other 3 (11.5) 1 (0.3) 
Source of household income   
 Planting crops 14 (53.8) 192 (60.0) 0.812 
 Working in a  
 factory 
3 (11.5) 53 (16.6) 
 Shopkeeping 5 (19.2) 36 (11.3) 
 Fishing, farming,  
 animal husbandry 
1 (3.9) 17 (5.3) 
 Working in  
 government 
0 6 (1.9) 
 Other or missing 3 (11.5) 16 (5.0) 
DENV serotype‡     
 DENV-1 21 (80.8) 249 (79.1) 0.892 
 DENV-2 2 (7.7) 35 (11.1) 
 DENV-3 0 2 (0.6) 
 DENV-4 3 (11.5) 28 (8.9) 
*Values are no. (%) patients except as indicated. DENV, dengue virus. 
†By Fisher test or 2 test.  
‡Data for 5 symptomatic patients were missing, and another patient was 
excluded from analysis because of co-infection with DENV-1 and DENV-2. 
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infected, consistent with other published sources. A study 
in Mexico found that the risk for infection for those liv-
ing with an index case-patient was twice that of someone 
living in a 50-meter radius of an index case-patient (31). 
This relationship was further described in a cluster study 
in Thailand that showed decreased risk for infection with 
increasing distance from the index case household (31). 
This clustering effect around an index case, however, 
seems to occur only on a short temporal scale, at least in 
urban settings (32).
Rates and severity of illness after infection with the 
different DENV serotypes differ widely (33,34). The only 
notable epidemiologic factor associated with asymptomatic 
DENV infections in our study was being family-related to 
the index case-patient. Another study showed that adaptive 
immune responses against DENV differ between persons 
with symptomatic and asymptomatic DENV infection (35), 
which might explain our observations. We found no other 
associated epidemiologic factor, including age or cluster 
effects. Although the ratio of male to female participants 
was twice as high among asymptomatic than symptomatic 
participants, this finding was not statistically significant, 
likely due to sample size. 
Although the size and duration of our study confer 
strength to our data, it might suffer from biases and limita-
tions, especially due to the small number of strictly asymp-
tomatic DENV-positive participants after stratifying by 
DENV serotype. We found dengue incidence rates high-
est in young children. These data might be biased because 
we focused on investigating clusters around an index case, 
perhaps overestimating the incidence in the general popula-
tion. DENV circulation, however, is intense in children in 
Cambodia, and these figures remain comparable to those 
found in dengue studies that use different methods, ranging 
from 20 to 80 per 1,000 person-seasons (1). Furthermore, 
we did not capture cases referred to the private sector, low-
ering our estimates somewhat. Healthy male workers often 
were away at the time of the investigations, possibly lead-
ing to an overestimation of DENV incidence. These work-
ers, however, are >18 years of age, but DENV infections 
occur mainly in persons <15 years of age in Cambodia (4).
Documentation bias might also have pulled our risk 
factor estimates toward the null. We did not document solid 
waste disposal in our study, but comparatively high Bre-
teau index values have been reported in Cambodia (29). In 
addition, we could have missed details or misrepresented 
implementation of mosquito-control measures. Despite the 
potential misclassification, mosquito-control measures re-
main nondifferential and likely had no major effect on our 
risk estimates.
Further, 7.5% of our DENV-infected participants re-
mained strictly asymptomatic. Aside from case definition 
issues we discuss, our method of screening for DENV 
around symptomatic cases might have underestimated the 
number of asymptomatic DENV infections. In addition, 
we did not enroll persons who tested negative for DENV 
IgM, NS1-capture ELISA, and qRT-PCR. Some of these 
persons might have been infected but not yet mounted an 
IgM response, so that NS1 and viral RNA titers had al-
ready receded to undetectable levels when we tested them. 
This strict case definition might have underestimated the 
incidence of asymptomatic cases, but a precise retrospec-
tive documentation of such cases would be extremely 
difficult. Similarly, we retrospectively conducted MAC-
ELISA on samples collected during perifocal investiga-
tions and identified 11 cases of IgM seroconversion in the 
absence of PCR- or NS1-positive tests. Even in the context 
of JEV cocirculation, some of these cases could have been 
true DENV infections, but including them would not have 
changed the overall estimated attack rate. Previous stud-
ies suggested virus serotype might affect severity and types 
of symptoms and observed that DENV-1 infections more 
frequently were associated with clinically apparent illness 
(36,37). Virus molecular analysis studies are ongoing to 
determine whether specific strains cause more asymptom-
atic infection than others. Furthermore, DENV infection in 
Cambodia occurs mainly in children who might be more 
likely to answer positively to daily-repeated questions on 
dengue symptoms, somewhat underestimating asymptom-
atic cases. Having implemented careful and thorough 10-
day clinical assessment of objective symptoms in each as-
ymptomatic DENV-positive participant, we believe these 
figures reflect the true proportion of strictly asymptomatic 
DENV infection in our setting. However, we collected 
our findings mainly in children with DENV-1 infection in 
Cambodia. Whether these findings are directly applicable 
to other epidemiologic settings, populations, or virus sero-
types or genotypes remains to be determined (33).
Finally, vaccination against JEV might have led to 
cross-protection against symptomatic dengue. Data on JEV 
vaccination were not collected during perifocal investiga-
tions. According to local health centers, however, JEV vac-
cine has been provided only recently and only for children 
9–24 months of age. In our study, only 3 children were 
DENV-positive in that age category.
Our study demonstrates that systematically relying on 
fever for DENV case definition can underestimate cases 
and hinder control efforts in areas with potential vectors 
and at risk for DENV introduction. We found 7.5% of 
DENV-infected participants remained strictly asymptom-
atic, which has wide-ranging epidemiologic consequences. 
Undetected sources can increase transmission (5), a factor 
that must be taken into account in future vaccine coverage 
and vaccine effectiveness studies. The attack rate differ-
ences observed around febrile index case-patients detected 
in village surveillance and index case-patients detected in 
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hospital surveillance deserve further study. In-depth virus 
(36) and human genetic studies could contribute useful in-
sights (33,35). Our strict definition of asymptomatic DENV 
infections should be considered when designing studies 
that aim to elucidate the pathophysiological mechanisms 
of dengue disease.
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Antimicrobial  
Drug Resistance  
and Gonorrhea 
Neisseria gonorrhoeae, the causative pathogen of gon-
orrhea, has been designated an urgent antimicrobial drug 
resistance threat by the Centers for Disease Control and 
Prevention. Since the introduction of antimicrobial drugs 
in the first half of the 20th century, N. gonorrhoeae has 
successively developed resistance to each antimicrobial 
agent recommended for gonorrhea treatment. In the Unit-
ed States, the prevalence of resistance in N. gonorrhoeae 
often varies by sex of partner and by geographic region. 
Prevalence is often greater in isolates from gay, bisexual, 
and other men who have sex with men than those from 
men who have sex only with women, and prevalence is 
often highest in the West and lowest in the South. Resis-
tant strains, in particular penicillinase-producing N. gon-
orrhoeae, fluoroquinolone-resistant N. gonorrhoeae, and 
gonococcal strains with re-
duced cephalosporin suscep-
tibility, seemed to emerge ini-
tially in the West (Hawaii and 
the West Coast) before spread-
ing eastward across the coun-
try. These geographic patterns 
seem to support the idea that 
importation of resistant strains 
from other regions of the 
world, such as eastern Asia, is 
a primary factor of the emer-
gence of resistant gonococci 
in the United States. Whereas 
antimicrobial drug prescribing patterns have been clearly 
associated with the emergence of resistance in other bac-
terial pathogens, the degree to which domestic antimicro-
bial use and subsequent selection pressure contributes to 
the emergence of gonococcal antimicrobial resistance in 
the United States is unclear. Using an ecologic approach, 
we sought to investigate the potential geographic and tem-
poral association between antimicrobial drug susceptibil-
ity among US N. gonorrhoeae isolates and domestic out-
patient antimicrobial drug prescribing rates in the United 
States during 2005–2013.
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